AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01963741 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: histamine
Description: Nasal challenge using 0.9% saline, was undertaken for exclusion of subjects hypersensitive to saline. The histamine nasal challenge could be initiated provided that NAR increase was \<30%. Ranges of 0.4 to 3.2 mg.mL-1 histamine diluents were applied for a double-fold increment approach at intervals of 3 minutes.
Study NCT04345315 — intervention group
Intervention type: GENETIC
Intervention: Next generation Sequencing (NGS) analysis
Description: analysis of genetic variability of virus and host
Study NCT02254707 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BILB 1941 ZW
Study NCT02254707 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT00615563 — intervention group
Intervention type: BEHAVIORAL
Intervention: NO BI Drug administered
Study NCT02245243 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delafloxacin
Description: Plasma pharmacokinetic parameters: AUC0-t, AUC0 inf, Cmax, Tmax, λz, t1/2, MRTinf, CL, CLnr, Vss, Vz
Study NCT00914030 — intervention group
Intervention type: OTHER
Intervention: Neuropsychological evaluation
Description: Study one: global/local processing, with a neutral prime (stimulus influencing the processing of the subsequent stimulus)Study two: global/ local processing with a prime whose elements are collinear.Study three: global/local processing with a prime whose elements are not collinear
Study NCT04345315 — intervention group
Intervention type: OTHER
Intervention: serum chemistry analysis
Description: Analysis of serum chemistry factors and coagulation panel in blood samples
Study NCT03909308 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Beach Tennis session
Description: The Beach Tennis training session will be composed by a warm up of 5 min of BT in which technical exercises (i.e., serve, volley, forehand and backhand) will be performed After that, 3 BT small games of 12 min with a 2 minute interval between games using the conventional rules of sport will be performed. Before the session and after each small game, data regarding heart rate, blood pressure and rate perceived exertion will be recorded.
Study NCT01354925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin treatment during Ramadan
Description: Insulin analogs will be used: Levemir and NovoMix70. The daily insulin dose will be calculated as follows: Sixty percent of the total daily dose will be used as the beginning daily dose at the first day of fasting. Sixty percent of the daily dose will be given as NovoMix70 before the Eftar (the main meal in the evening that breaks the fast). Forty percent of the amount will be given as Levemir (Early in the morning before the beginning of fasting.
Study NCT02547129 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Static Antibiotic Spacer Surgical Implant
Description: Joint spacer for treatment of joint infection
Study NCT02547129 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Articulating Antibiotic Spacer Surgical Implant
Description: Joint spacer for treatment of joint infection
Study NCT06267235 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary protein restriction
Description: The consumption of different diets restricted in protein replaced by either carbohydrate or fat and an habitual diet.
Study NCT01163994 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ceftriaxone
Description: intravenously, 2 g, qd, 15 days
Study NCT01163994 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doxycycline
Description: orally, 100 mg, bid, 15 days
Study NCT01163994 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: erythema migrans patients treated with doxycycline
Description: orally, 100 mg, bid, 15 days
Study NCT00621218 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tretinoin gel 0.05%
Description: Apply tretinoin gel, 0.05% topically once or twice daily to female subjects with rosacea
Study NCT01354925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care during Ramadan according to physicians decision
Study NCT03420274 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NEST
Description: This is a point-of-care shared decision-making instrument.
Study NCT03420274 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Usual care
Description: This group will utilize usual care with respect to healthcare provider practice for education and counseling.
Study NCT04311125 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mini posterior approach Total Hip Replacement
Description: Total hip replacement in patients suffering from hip osteoarthritis using the mini posterior approach
Study NCT04311125 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior approach total hip replacement without a traction table
Description: Mini Anterior approach total hip replacement in patients suffering from hip osteoarthritis without the aid of a traction table
Study NCT04311125 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior approach total hip replacement with a traction table
Description: Mini Anterior approach total hip replacement in patients suffering from hip osteoarthritis with the aid of a traction table
Study NCT01040442 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: vibration stimuli
Description: A single physical therapist performed the intervention using a Novafon SK2‡ vibratory stimulation device at a frequency of 100 Hz and sway amplitude of 2 mm. The participants of the experimental group received vibratory stimulation, applied slowly by sliding the head of the device over the entire plantar region for ten minutes for each foot at every session. During the intervention, the participants remained in the supine position on an examination table.
Study NCT00954499 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tactile stimulation added to Standard care
Description: * Parent rubs the infant's skin near the injection site just before, during and after the injection.~* Fast injection technique without aspiration.~* Oral sucrose 2 minutes before first injection.~* Parent holds infant close.
Study NCT00954499 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: * Fast injection technique without aspiration.~* Oral sucrose 2 minutes before first injection.~* Parent holds infant close.
Study NCT03875742 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Ultraplex 360(Braun)
Description: This group will use as first needle the ultraplex 360 (Braun)
Study NCT03875742 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: STIMUPLEX D SH, 30°(Braun)
Description: This group will use as first needle the  STIMUPLEX D SH, 30° (Braun)
Study NCT01542710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ganfort
Description: Bimatoprost/Timolol fixed combination
Study NCT01542710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duotrav
Description: Fixed combination of Travoprost and Timolol
Study NCT00258817 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza Virus Vaccine (Fluzone®)
Description: 0.25 mL, Intramuscular (Day 0 and Day 28)
Study NCT00258817 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza Virus Vaccine (Fluzone®)
Description: 0.25 mL, Intramuscular (Day 0)
Study NCT02243735 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous fumarate
Description: Patients randomized to standard care with ferrous fumarate will receive three tablets of 200 mg daily from randomisation until day before surgery
Study NCT02243735 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ferric(III)carboxymaltose
Description: Patients randomized to intravenous iron (ferric(III)carboxymaltose) will be dosed according to Summary of Product Characteristics (SPC) depending on body weight and Hb value and administered in one or two infusions with one week in between. A maximum dose of 1000mg or 15mg/kg per week will be administered
Study NCT04102527 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Patients have to complete the study questionnaires every 2 months :~* Digestive Functional Score of Neurological Patients~* Bowel Function Index~* Severity score for constipation~* Bristol Scale~* Constipation assessment scale~* Estimate scale of risk of constipation
Study NCT04096287 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PNT001
Description: PNT001 diluted in 5% dextrose
Study NCT04096287 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 5% dextrose
Study NCT01593592 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri
Description: Will receive triple therapy (omeprazole 20 mg b.i.d., amoxicillin 1000 mg b.i.d, clarithromycin 500mg b.i.d) and L. reuteri (is a mixture of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475, will be delivered a dose of 1x108 CFU each strain, means giving daily chewable tablet containing 2x108 CFU/day) for 2 weeks followed by L. reuteri for another 2 weeks.
Study NCT01593592 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Will receive triple therapy (omeprazole 20 mg b.i.d., amoxicillin 1000 mg b.i.d, clarithromycin 500mg b.i.d) and a placebo (1.5 mg per dose as chewable tablets) for 2 weeks followed by placebo for another 2 weeks.
Study NCT01593592 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Omeprazole
Description: All patients will receive omeprazole 20 mg b.i.d for 2 week
Study NCT01593592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: All patients will receive omeprazole 20 mg b.i.d for 2 week
Study NCT01593592 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amoxicillin
Description: amoxicillin 1000 mg b.i.d for 2 weeks
Study NCT01593592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: amoxicillin 1000 mg b.i.d for 2 weeks
Study NCT01593592 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Clarithromycin
Description: clarithromycin 500mg b.i.d for 2 weeks
Study NCT01593592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Description: clarithromycin 500mg b.i.d for 2 weeks
Study NCT00644488 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-641988 (AR#2)
Description: Tablets, Oral, 20 mg, 40 mg, 60 mg, 100 mg, once daily, 24 weeks
Study NCT02474602 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active or Placebo Phototherapy (MR4)
Description: Participants performed a strength training. Forty-eight subjects practiced a training protocol with 80% of the load, measured through 1-repetition maximum test. The strength training lasted 12 weeks and the evaluations were done monthly. Phototherapy, active or placebo, were applied in 6 different points of quadriceps muscle depending the group randomized, before and after each training session.
Study NCT00621218 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: vehicle
Description: Apply Atralin Gel vehicle topically once or twice daily to female subjects with rosacea.
Study NCT03002168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Alpha-cyclodextrin
Description: Alpha-cyclodextrin is approved by the Food and Drug Administration as a dietary ingredient.
Study NCT02896686 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Control CT
Description: At the end of the follow up (12 Months) a CT scan will be done. Radiologically the incisional hernia is defined as a solution of continuity of the abdominal wall seen on the abdominal CT scan with the patient at rest.~The radiologist is blinded to the patient's history and the technique used for fascial closure.
Study NCT02896686 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Control CT
Description: At the end of the follow up (12 Months) a CT scan will be done. Radiologically the incisional hernia is defined as a solution of continuity of the abdominal wall seen on the abdominal CT scan with the patient at rest.~The radiologist is blinded to the patient's history and the technique used for fascial closure.
Study NCT02269930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon beta-1a
Description: Administered as subcutaneous injection
Study NCT02269930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rebif
Description: Administered as subcutaneous injection
Study NCT02896686 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical Follow Up
Description: The presence of incisional hernia was evaluated by physical examination at scheduled clinical visits (3 and 6 months after surgery) Clinically, an incisional hernia is defined as the presence of a reducible bulge or protrusion at the laparotomy incision scar, palpable during the Valsalva maneuver.
Study NCT02896686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Follow Up
Description: The presence of incisional hernia was evaluated by physical examination at scheduled clinical visits (3 and 6 months after surgery) Clinically, an incisional hernia is defined as the presence of a reducible bulge or protrusion at the laparotomy incision scar, palpable during the Valsalva maneuver.
Study NCT03565380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-week community-based multi-model Tai Chi rehabilitation program
Description: Participants will receive 12 x 90 minute sessions of supervised exercises over 12 weeks. In addition to usual care, supervised exercise will be held at the Center of Sports Training and Rehabilitation inside the University and each class will be restricted to no more than 8 participants to ensure sufficient personalized attention. Each training session involves warm-up together with stretching of lower extremity muscles, strengthening exercises of the major lower extremity muscle groups by Theraband, balancing exercise, Tai Chi training, and rest/ cool-down. All lower-extremity exercises will be performed bilaterally.
Study NCT02896686 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reinforcement with Light Polypropylene Mesh
Description: Reinforcement with Light Polypropylene Mesh
Study NCT00387829 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DuraGen Plus Adhesion Barrier Matrix
Description: Application of DuraGen Plus Adhesion Barrier Matrix in spine surgery
Study NCT03565380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual post-operative care
Description: No intervention will be provided
Study NCT03002168 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets identical in appearance to the active comparator
Study NCT04151654 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Footwear Assessment Score
Description: It was assessed using the Sharpened Romberg test and Single Leg Stance test for static balance. It was assessed Berg Balance Scale for dynamic balance, and Timed Up and Go test for functional performance. Balance and performance tests were done with and without footwear in all individuals.
Study NCT01693640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abatacept
Description: Weekly injections with Abatacept 125 mg over 6 months
Study NCT01951833 — intervention group
Intervention type: DEVICE
Intervention: EasyOne Pro and Ecomedics
Description: LCI will be assessed with 2 different devices : EasyOne Pro and Ecomedics
Study NCT03487120 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: facet joint denervation
Description: Bipolar electrocautery
Study NCT02493712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose
Description: 6 capsules of IBD98-M, twice a day
Study NCT02493712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose
Description: 4 capsules of IBD98-M
Study NCT02493712 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03006549 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emergency Manual (Crisis Checklist)
Description: participants will have an Emergency Manual available to them during the crisis simulation scenario.
Study NCT04816942 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Convalescent Plasma
Description: Two units of ABO compatible COVID-19 convalescent plasma will be administered.
Study NCT01607489 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Dual-energy computed tomography investigation
Description: 1x 20ml Ultravist (370mg J/ml)3-5ml/s,~1x 70ml Ultravist (370mg J/ml)3-5ml/s Contrast agent administration
Study NCT01080157 — intervention group
Intervention type: DEVICE
Intervention: SCOUT DS measurement
Description: Non-invasive 3-5 volar forearm scan
Study NCT01716221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bupropion & Citalopram
Study NCT01716221 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupropion & Placebo
Study NCT01716221 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo & Citalopram
Study NCT01716221 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo & Placebo
Study NCT03567811 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Submaximal bicycle exercise stress test on Days 1 and 2
Description: Identical submaximal stress tests were performed on both days to see if Day 1 exercise reduced performance on Day 2, or caused changes between BOLD scans during cognitive testing between Day 1 and Day 2.
Study NCT03095365 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dry needling
Description: Insertion of solid filament needles in the muscle
Study NCT03095365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Insertion of solid filament needles in the muscle
Study NCT03095365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education
Description: Explanation of the functioning of the central nervous system, the differences between acute pain and chronic pain and the importance of thoughts and beliefs in the processing and chronification of pain
Study NCT03095365 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Electrotherapy: Transcutaneous electrical nerve stimulation and microwaves
Study NCT04563845 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3640254
Description: GSK3640254 will be administered.
Study NCT04563845 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GSK3640254
Description: GSK3640254 will be administered.
Study NCT03002168 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Triolein radiolabeled with 100 microcuries of 3^Hydrogen
Description: A MicroCurie (µCi) is a measure of radioactivity.
Study NCT03002168 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Triolein radiolabeled with 100 microcuries of 3^Hydrogen
Description: A MicroCurie (µCi) is a measure of radioactivity.
Study NCT03002168 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Tripalmitin radiolabeled with 20 microcuries of 14^Carbon
Description: A MicroCurie (µCi) is a measure of radioactivity.
Study NCT03002168 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Tripalmitin radiolabeled with 20 microcuries of 14^Carbon
Description: A MicroCurie (µCi) is a measure of radioactivity.
Study NCT01184651 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaires/Interviews
Description: Girls answer questions about activities and interests, school, feelings about being a girl, stage of physical development, and family relationships during a home interview , provide saliva samples, and participate in phone interviews to answer questions about daily activities .
Study NCT01184651 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaires/Interviews
Description: Parents complete questionnaires about their daughter's activities, interests, and behaviors, educational goals, family demographics and relationships, grades, diagnosis and treatment of her CAH, their own activities, interests, and thoughts and feelings about being male or female. Parents answer questions during phone interviews about their daughters daily activities.
Study NCT03125798 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LigaSure™
Description: LigaSure™ is supposed to provide improved closure of lymphatic and blood vessels during mediastinal lymph nodes dissection.
Study NCT03125798 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Monopolar electrocautery
Description: Monopolar electrocautery will be used according to the standard technique for the mediastinal lymph node dissection.
Study NCT02261376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-1971a
Description: DS-1971a is supplied as a powder or crystals and will be given as an oral suspension with Bitrex® (taste masking agent). Each subject will receive a single oral dose of 200 mg DS 1971a .
Study NCT04563845 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered.
Study NCT03752814 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SYNOSTE Nitinail System
Description: Mode of application: 1. Implantation surgery: osteotomy and antegrade implantation of SNS in femur for distraction osteogenesis (callotasis), 2. distraction osteogenesis (implant lengthening phase), 3. Bone healing (implant as stabilizing element during consolidation phase), 4. Explantation after consolidation.